Drug
Dexmedetomidine +Ketamine
Dexmedetomidine +Ketamine is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 4Post-market surveillance
2(66.7%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 11 (33.3%)
Phase 42 (66.7%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
Dexmedetomidine-Ketamine Infusion in Breast Surgeries
NCT04048226
completedphase_1
Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma
NCT04621526
completedphase_4
The Effect of Opioid Free Anesthesia in Bariatric Surgeries
NCT04048200
Clinical Trials (3)
Showing 3 of 3 trials
NCT04048226Phase 4
Dexmedetomidine-Ketamine Infusion in Breast Surgeries
NCT04621526Phase 1
Monitored Anesthesia Care: Dexmedetomidine-Ketamine Versus Dexmedetomidine- Propofol For Chronic Subdural Hematoma
NCT04048200Phase 4
The Effect of Opioid Free Anesthesia in Bariatric Surgeries
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3